Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Effectiveness of a SARS-CoV-2 mRNA vaccine booster dose for prevention of infection, hospitalization or death in two nation-wide nursing home systems

View ORCID ProfileKevin W. McConeghy, Barbara Bardenheier, Andrew W. Huang, Elizabeth M. White, Richard A. Feifer, Carolyn Blackman, Christopher M. Santostefano, Yoojin Lee, Frank DeVone, Christopher W. Halladay, James L. Rudolph, Andrew R. Zullo, Vincent Mor, Stefan Gravenstein
doi: https://doi.org/10.1101/2022.01.25.22269843
Kevin W. McConeghy
1Center of Innovation in Long-Term Services and Supports, Veterans Administration Medical Center, Providence, Rhode Island, United States
2Department of Health Services, Policy and Practice, School of Public Health, Brown University, Providence, Rhode Island, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kevin W. McConeghy
  • For correspondence: Kevin_mcconeghy@brown.edu kevin.mcconeghy@va.gov
Barbara Bardenheier
2Department of Health Services, Policy and Practice, School of Public Health, Brown University, Providence, Rhode Island, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew W. Huang
2Department of Health Services, Policy and Practice, School of Public Health, Brown University, Providence, Rhode Island, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth M. White
2Department of Health Services, Policy and Practice, School of Public Health, Brown University, Providence, Rhode Island, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard A. Feifer
3Genesis HealthCare, Kennett Square, Pennsylvania, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carolyn Blackman
3Genesis HealthCare, Kennett Square, Pennsylvania, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher M. Santostefano
2Department of Health Services, Policy and Practice, School of Public Health, Brown University, Providence, Rhode Island, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoojin Lee
2Department of Health Services, Policy and Practice, School of Public Health, Brown University, Providence, Rhode Island, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank DeVone
1Center of Innovation in Long-Term Services and Supports, Veterans Administration Medical Center, Providence, Rhode Island, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher W. Halladay
1Center of Innovation in Long-Term Services and Supports, Veterans Administration Medical Center, Providence, Rhode Island, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James L. Rudolph
1Center of Innovation in Long-Term Services and Supports, Veterans Administration Medical Center, Providence, Rhode Island, United States
2Department of Health Services, Policy and Practice, School of Public Health, Brown University, Providence, Rhode Island, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew R. Zullo
1Center of Innovation in Long-Term Services and Supports, Veterans Administration Medical Center, Providence, Rhode Island, United States
2Department of Health Services, Policy and Practice, School of Public Health, Brown University, Providence, Rhode Island, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Mor
1Center of Innovation in Long-Term Services and Supports, Veterans Administration Medical Center, Providence, Rhode Island, United States
2Department of Health Services, Policy and Practice, School of Public Health, Brown University, Providence, Rhode Island, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Gravenstein
1Center of Innovation in Long-Term Services and Supports, Veterans Administration Medical Center, Providence, Rhode Island, United States
2Department of Health Services, Policy and Practice, School of Public Health, Brown University, Providence, Rhode Island, United States
4Warren Alpert Medical School of Brown University, Providence, Rhode Island, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background A SARS-CoV-2 vaccine booster dose has been recommended for all nursing home residents. However, we lack effectiveness data on boosters preventing infection, death and hospitalization in this frail population.

Methods We emulated nested target trials in two large nursing home systems in parallel to evaluate the effectiveness of a SARS-CoV-2 mRNA vaccine booster at preventing infection, hospitalization, or death. Residents who completed a 2-dose series of the mRNA vaccine and were eligible for a booster were included in from September 22, 2021 to November 5, 2021. Outcomes were measured through December 18, 2021, including test-confirmed SARS-CoV-2 infection, hospitalization, or death. The vaccine effectiveness at day 42 was estimated with a Kaplan-Meier estimator, both unadjusted and weighted with the inverse probability of treatment.

Results The two NH systems were large and multi-state, System 1 included 200 NH (8,538 control and 5,721 boosted residents) and System 2 included 127 NHs (4,100 control and 2,291 boosted residents). Booster vaccination reduced infections by 50.4% (95% Confidence Interval [CI]: 29.4%, 64.7%) SARS-CoV-2 infections in System 1 and 58.2% (32.3%, 77.8%) in System 2. Boosted residents in System 1 also had a 97.3% (86.9%, 100.0%) reduction in SARS-CoV-2 associated death, but too few events for comparison in System 2.

Conclusions During a Delta predominant period, SARS-CoV-2 booster vaccination significantly reduced infection in two U.S. nursing home systems. In the larger System 1 a 97% reduction in SARS-CoV-2 related death was also observed. These findings strongly support administration of vaccine boosters to nursing home residents.

Competing Interest Statement

KWM, BB, SG and ARZ have received investigator-initiated to their institutions from Sanofi-Pasteur, Seqirus and Pfizer for other non-COVID-19 vaccine-related work. VM serves as Chair of the Scientific Advisory Committee at NaviHealth, Inc, was former Chair of the Independent Quality Committee at HCR ManorCare, and is the former Director of PointRight Inc, where he holds less than 1% equity; and received personal fees from NaviHealth outside the submitted work. The remaining authors declare that they have no relevant financial interests. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Funding Statement

This work was supported by the National Institute on Aging (3P01AG027296-11S1, PI: Vincent Mor and 3U54AG063546-02S2, PI: Vincent Mor & Sarah Berry). Dr. Zullo was also supported by grants R01AG045441, RF1AG061221, R01AG065722, and R21AG061632 from the National Institute on Aging (NIA) and by grant U54GM1156775 from the National Institute of General Medical Sciences (NIGMS).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Brown University institutional review board (IRB) and the VA data was approved by the Providence VA Medical Center IRB

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Disclaimer: The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.

Data Availability

The data presented in this study contains protected health information and cannot be shared in its person-level form. However the authors can commit to responding to reasonable inquires about the data and sharing summary-level information when requested.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 28, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Effectiveness of a SARS-CoV-2 mRNA vaccine booster dose for prevention of infection, hospitalization or death in two nation-wide nursing home systems
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Effectiveness of a SARS-CoV-2 mRNA vaccine booster dose for prevention of infection, hospitalization or death in two nation-wide nursing home systems
Kevin W. McConeghy, Barbara Bardenheier, Andrew W. Huang, Elizabeth M. White, Richard A. Feifer, Carolyn Blackman, Christopher M. Santostefano, Yoojin Lee, Frank DeVone, Christopher W. Halladay, James L. Rudolph, Andrew R. Zullo, Vincent Mor, Stefan Gravenstein
medRxiv 2022.01.25.22269843; doi: https://doi.org/10.1101/2022.01.25.22269843
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Effectiveness of a SARS-CoV-2 mRNA vaccine booster dose for prevention of infection, hospitalization or death in two nation-wide nursing home systems
Kevin W. McConeghy, Barbara Bardenheier, Andrew W. Huang, Elizabeth M. White, Richard A. Feifer, Carolyn Blackman, Christopher M. Santostefano, Yoojin Lee, Frank DeVone, Christopher W. Halladay, James L. Rudolph, Andrew R. Zullo, Vincent Mor, Stefan Gravenstein
medRxiv 2022.01.25.22269843; doi: https://doi.org/10.1101/2022.01.25.22269843

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8790)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1864)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (492)
  • Hematology (207)
  • HIV/AIDS (395)
  • Infectious Diseases (except HIV/AIDS) (10567)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1756)
  • Nursing (103)
  • Nutrition (266)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (965)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (266)
  • Primary Care Research (219)
  • Psychiatry and Clinical Psychology (1845)
  • Public and Global Health (3986)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (535)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (80)